MiniMed Group (MMED) Stock: Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 31, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 1 added, 0 cutMore adding

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about MMED filings

Are insiders buying or selling MiniMed Group, Inc. Common Stock (MMED) stock?

Neither. MiniMed Group, Inc. Common Stock (MMED) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded MMED recently?

None. No member of Congress disclosed a MMED trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MMED smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on MMED

Lean long1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
No recent insider filings found
Politicians
No recent politician filings found
Funds
Lean long3 added · 0 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about MMED filings

Are insiders buying or selling MiniMed Group, Inc. Common Stock (MMED) stock?

Neither. MiniMed Group, Inc. Common Stock (MMED) insiders filed no open-market purchases or sales in the 90 days to Oct 31, 2026, according to SEC Form 4 filings.

Which members of Congress have traded MMED recently?

None. No member of Congress disclosed a MMED trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this MMED smart-money data?

Funds

What funds are doing

4 moves · 6 mo

Buys/Adds$131.1M

Buys/Adds (3)

CI
Citadel
Ken Griffin · Q1 2026 13F
$42.5M
bought
Signals like this: n=3224, 54% finished lower at D15, median -0.8% vs SPY -0.4%
MI
Millennium
Israel Englander · Q1 2026 13F
$38.7M
bought
BR
BlackRock
Q2 2026 13F
$29.5M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%

1 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 1 moves

Other smart money signals

Activist stakes, short interest & more

3 items

F1
Filing 13d GModerate
CAPITAL VENTURES INTERNATIONAL filed SC 13G on MiniMed Group, Inc. (passive 7.80% stake)
F1
Filing 13d GLight
Medtronic plc filed SC 13G/A on MiniMed Group, Inc. (passive 0.00% stake)
SI
Short Interest ChangeModerate
short-volume tape softening: latest 17.9% fell 43.2pp vs 20d avg 61.0%

Unlock everything for $29/month

Unlock for $29/month

Reported Sep 8, 2026

Earnings came in $0.04 a share above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Sep 8, 2026

Period ending

Jul 31, 2026

Earnings per share

$0.13+$0.04 beat

$0.10 expected

Revenue

$843.0M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jul 31, 2026Reported Sep 8, 2026	$0.13est. $0.10	+$0.04beat	$843.0MSEC filing	+16.6%from $723.0M
Apr 30, 2026Reported Jun 29, 2026	-$0.60est. -$0.22	-$0.38miss	$837.0MAlpha Vantage	No year-ago quarter
Jan 23, 2026Reported Apr 17, 2026	$0.08est. $0.21	-63.75%miss	$790.0MSEC filing	+15.0%from $687.0M
Jul 25, 2025Reported Sep 8, 2026	Not on file	No estimate	$723.0MSEC filing	No year-ago quarter
Jan 24, 2025Reported Apr 17, 2026	Not on file	No estimate	$687.0MSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $19.01
52-wk high: $24.43
High: $19.55
52-wk low: $10.65
Low: $19.01
Prev close: $19.21
Mkt cap: $5.42B
ROE: -8.7%
P/S: 1.7x
P/B: 1.5x
Profit margin: -10.2%
Op margin: +0.5%

Oct 2025 to Jul 2026

What it sold, what it cost, what was left.

RevenueProfit

Oct 2025Jan 2026Apr 2026Jul 2026

Income statement, 4 periods, all values in US dollars
USD	Oct 2025	Jan 2026	Apr 2026	Jul 2026
What came in
RevenueTotal revenue	$752.0M	$790.0M	$837.0M	$843.0M
Cost of what it soldCost of revenue	$324.0M	$428.0M	$357.0M	$378.0M
Gross profit	$428.0M	$362.0M	$480.0M	$465.0M
What it spent
Research and development	$111.0M	$114.0M	$99.0M	$115.0M
Sales and adminSelling, general and administrative	$318.0M	$309.0M	$299.0M	$312.0M
Other operating costsOperating costs not itemised in the filing's summary	$9.0M	$32.0M	—	—
Total operating expenses	$438.0M	$455.0M	$398.0M	$427.0M
What was left
Operating profitOperating income	-$10.0M	-$93.0M	$82.0M	$38.0M
Profit before tax	-$12.0M	-$99.0M	-$90.0M	$4.0M
TaxIncome tax expense	$19.0M	$12.0M	$93.0M	$4.0M
Net profitNet income	-$27.0M	-$119.0M	-$183.0M	$0
EBITDAEarnings before interest, tax, depreciation, amortisation	$29.0M	-$60.0M	$121.0M	$79.0M

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

35 / 100

RSI 14

47balanced

20D volatility

54%annualized

52-week range

$19.25

$10.65$24.43

20D support

$16.55recent floor

20D resistance

$20.17recent ceiling

Returns

5D +5.2%20D -1.8%60D +3.7%

Price vs moving averages

SMA20 +3.1%SMA50 -4.7%

Volume pace

6.33xvs prior 20D

11 macro signals shaping MMED right now

Unlock sector rotation, regime shifts, and macro event windows tied to this stock.

Unlock the full results

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jul 31, 2026Sep 8, 2026

$0.13est. $0.10

+$0.04

$843.0MSEC filing

+16.6%from $723.0M

Apr 30, 2026Jun 29, 2026

-$0.60est. -$0.22

-$0.38

$837.0MAlpha Vantage

No year-ago quarter

Jan 23, 2026Apr 17, 2026

$0.08est. $0.21

-63.75%

$790.0MSEC filing

+15.0%from $687.0M

Jul 25, 2025Sep 8, 2026

Not on file

No estimate

$723.0MSEC filing

No year-ago quarter

Jan 24, 2025Apr 17, 2026

Not on file

No estimate

$687.0MSEC filing

No year-ago quarter

Income statement, 4 periods, all values in US dollars
USD	Oct 2025	Jan 2026	Apr 2026	Jul 2026
What came in
RevenueTotal revenue	$752.0M	$790.0M	$837.0M	$843.0M
Cost of what it soldCost of revenue	$324.0M	$428.0M	$357.0M	$378.0M
Gross profit	$428.0M	$362.0M	$480.0M	$465.0M
What it spent
Research and development	$111.0M	$114.0M	$99.0M	$115.0M
Sales and adminSelling, general and administrative	$318.0M	$309.0M	$299.0M	$312.0M
Other operating costsOperating costs not itemised in the filing's summary	$9.0M	$32.0M	—	—
Total operating expenses	$438.0M	$455.0M	$398.0M	$427.0M
What was left
Operating profitOperating income	-$10.0M	-$93.0M	$82.0M	$38.0M
Profit before tax	-$12.0M	-$99.0M	-$90.0M	$4.0M
TaxIncome tax expense	$19.0M	$12.0M	$93.0M	$4.0M
Net profitNet income	-$27.0M	-$119.0M	-$183.0M	$0
EBITDAEarnings before interest, tax, depreciation, amortisation	$29.0M	-$60.0M	$121.0M	$79.0M

USD

Oct 2025

Jan 2026

Apr 2026

Jul 2026

What came in

RevenueTotal revenue

$752.0M

$790.0M

$837.0M

$843.0M

Cost of what it soldCost of revenue

$324.0M

$428.0M

$357.0M

$378.0M

Gross profit

$428.0M

$362.0M

$480.0M

$465.0M

What it spent

Research and development

$111.0M

$114.0M

$99.0M

$115.0M

Sales and adminSelling, general and administrative

$318.0M

$309.0M

$299.0M

$312.0M

Other operating costsOperating costs not itemised in the filing's summary

$9.0M

$32.0M

—

Total operating expenses

$438.0M

$455.0M

$398.0M

$427.0M

What was left

Operating profitOperating income

-$10.0M

-$93.0M

$82.0M

$38.0M

Profit before tax

-$12.0M

-$99.0M

-$90.0M

$4.0M

TaxIncome tax expense

$19.0M

$12.0M

$93.0M

$4.0M

Net profitNet income

-$27.0M

-$119.0M

-$183.0M

EBITDAEarnings before interest, tax, depreciation, amortisation

$29.0M

-$60.0M

$121.0M

$79.0M

MiniMed Group, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about MMED filings

Smart money on MMED

Questions about MMED filings

What funds are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in $0.04 a share above what analysts expected.

What the street expects next

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

MiniMed Group, Inc. Common Stock

Smart money at a glance

What do analysts expect?

Questions about MMED filings

Smart money on MMED

Questions about MMED filings

What funds are doing

How top traders are positioned

Activist stakes, short interest & more

Unlock everything for $29/month

Earnings came in $0.04 a share above what analysts expected.

What the street expects next

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

MiniMed Group, Inc. Common Stock

Overview

Questions about MMED filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.

MiniMed Group, Inc. Common Stock

Overview

Questions about MMED filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Macro

Ask it in Claude or ChatGPT.